iShares Dow Jones US Pharmaceuticals ETF : IHE

IHE

Stock Data

$100.13

$1.00 (1.01%)

Asset Type

N/A

Exchange

N/A

Currency

N/A

Country

N/A

Sector

N/A

Industry

N/A

All IHE Articles

3 Articles

Omor Ibne Ehsan | May 19, 2026 at 4:19 PM EDT

Ditch or Double Down on This Pharma ETF as Trump Adjusts Drug Prices?

The iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) is the rare fund that has spent the past year being publicly threatened by…

John Seetoo | Mar 24, 2026 at 10:07 AM EDT

With Two Companies Dictating Everything, IHE Is Riskier Than Most Investors Realize

Half of every dollar invested in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) rides on just two companies pulling in opposite directions…

Omor Ibne Ehsan | Dec 11, 2025 at 11:06 AM EST

3 Dividend ETFs to Buy and Hold for Life if the Market Crashes

Dividend ETFs may be the best investment you can make today. The iShares 20+ Year Treasury Bond ETF (NASDAQ:TLT), iShares…

iShares Dow Jones US Pharmaceuticals ETF : IHE

IHE

$100.13

All IHE Articles

Ditch or Double Down on This Pharma ETF as Trump Adjusts Drug Prices?

With Two Companies Dictating Everything, IHE Is Riskier Than Most Investors Realize

3 Dividend ETFs to Buy and Hold for Life if the Market Crashes

Tech Experts Warn: Memory Shortage Crisis Won’t Ease Until 2028, and RAM Makers Have No Incentive to Fix It

Why U.S. AI Restrictions Could Give China an Unexpected Advantage Following the Android Playbook

Wall Street Tech Analyst: Micron Could 4x If the AI Cycle Lasts Through 2030

Make Sure You Calculate Your 401(k) RMD Before IRMAA Surcharges Hit Your Medicare

A 25-Year-Old Built $500K in Stocks, 13 Rentals, and $10K a Month, While Spending Just $24K a Year

Tech Experts Warn: Memory Shortage Crisis Won’t Ease Until 2028, and RAM Makers Have No Incentive to Fix It

Why U.S. AI Restrictions Could Give China an Unexpected Advantage Following the Android Playbook

iShares Dow Jones US Pharmaceuticals ETF : IHE

IHE

$100.13

All IHE Articles

Ditch or Double Down on This Pharma ETF as Trump Adjusts Drug Prices?

With Two Companies Dictating Everything, IHE Is Riskier Than Most Investors Realize

3 Dividend ETFs to Buy and Hold for Life if the Market Crashes

Tech Experts Warn: Memory Shortage Crisis Won’t Ease Until 2028, and RAM Makers Have No Incentive to Fix It

Why U.S. AI Restrictions Could Give China an Unexpected Advantage Following the Android Playbook

Wall Street Tech Analyst: Micron Could 4x If the AI Cycle Lasts Through 2030

Featured Reads

Make Sure You Calculate Your 401(k) RMD Before IRMAA Surcharges Hit Your Medicare

A 25-Year-Old Built $500K in Stocks, 13 Rentals, and $10K a Month, While Spending Just $24K a Year